Summary
In the basal state the body utilizes glucose at a rate of 2.2–2.3 mg· kg-1·min-1; of this approximately 1.2–1.3 mg · kg-1 · min-1 is oxidized, while the remaining 1.0 mg · kg-1·min-1 must be utilized by non-oxidative pathways. Little information is, however, available concerning the insulin dependency of these processes. To examine the role of basal insulin levels on glucose oxidation, glucose storage and total body glucose uptake, somatostatin (10 μg/min) was infused for 2 h in nine volunteers while maintaining plasma glucose concentration constant at basal levels by an exogenous glucose infusion. Basal plasma insulin fell by about 50% (13±2 to 7±1mU/l, p<0.01). Total body glucose metabolism (3H-3-glucose) declined from 2.3±0.1 to 1.9±0.1mg· kg-1·min-1 (p<0.01). This decrease was entirely accounted for by a fall in basal glucose oxidation (measured by indirect calorimetry) from 1.3±0.1 to 0.7±0.1 mg·kg-1·min-1 (p< 0.001). To assess the specific role of insulin deficiency in the decline in glucose oxidation, subjects were restudied with somatostatin plus basal insulin replacement (0.07 mg ·kg-1· min-1). Fasting insulin concentration (14±1 mU/1) remained constant during somatostatin plus insulin infusion (13±1mU/l) and basal rates of glucose oxidation (1.2±0.1 mg · kg-1·min-1) and total body glucose uptake did not change significantly. After 2 h, the basal insulin infusion was stopped and somatostatin was continued. Over the subsequent hour, glucose oxidation declined by 0.4±0.1 mg· kg-1 · min-1. This decrease was associated with a parallel decrease in total body glucose uptake of 0.4±0.1 mg·kg-1 ·min-1. These results indicate that approximately 50% of basal glucose oxidation is dependent upon basal insulin secretion. Non-oxidative pathways of glucose metabolism under basal conditions appear to be insulin independent.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
DeFronzo RA, Jacot E, Maeder E, Felber JP, Wahren J (1980) The effect of insulin on the disposal of intravenous glucose results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30: 1000–1007
Rizza RA, Mandarino LJ, Gerich JE (1981) Dose response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 240: E630-E639
Kolterman OG, Insel J, Saekow M, Olefsky JM (1980) Mechanisms of insulin resistance in human obesity — Evidence for receptor and postreceptor defects. J Clin Invest 65: 1272–1284
Ferrannini E, Wahren J, Felig P, DeFronzo RA (1980) The role of fractional glucose extraction in the regulation of splanchnic glucose metabolism in normal and diabetic man. Metabolism 29: 28–35
DeFronzo RA (1979) Glucose intolerance and aging. Evidence for tissue insensitivity to insulin. Diabetes 28: 1095–1101
Jéquier E (1981) Long-term measurement of energy expenditure in: direct or indirect calorimetry? In: Björntorp P, Cairella M, Howard AN (eds) Recent advances in obesity research III, John Libbey, London, pp 130–135
DeFronzo RA, Tobin JD, Andres R (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237: E214-E223
Statist Bull Metrop Life Insur Co (1959) 40, Nov–Dec
Dubois EF (1936) Basal metabolism in health and disease, 3rd edn. Lea & Febiger, Philadelphia, pp 20–36
Lusk G (1924) Animal calorimetry: analysis of the oxidation of mixtures of carbohydrate and fat. J Biol Chem 59: 41–42
Bursztein S, Saphar P, Glaser P, Taitelmann U, de Myttenaere S, Nedey R (1977) Determination of energy metabolism from respiratory functions alone. J Appl Physiol 42: 117–119
Herbert V, Lau KS, Gottlieb CW, Bleicher SJ (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab 25: 1375–1384
Aguilar-Parada E, Eisentraut AM, Unger RH (1969) Pancreatic glucagon secretion in normal and diabetic subjects. Am J Med Sci 257: 415–419
Dole VP, Meinertz M (1960) Microdetermination of long-chain fatty acids in plasma and tissues. J Biol Chem 235: 2595–2599
Heindel JJ, Cushman SW, Jeanrenaud B (1974) Cell-associated fatty acid levels and energy-requiring processes in mouse adipocytes. Am J Physiol 226: 16–24
Williamson DH, Mellamby J (1974) D-(-)-3-hydroxybutyrate; acetoacetate; Methods of enzymatic analysis. Bergmeyer HU (Ed). Verlag Chemi, Weinheim RFA and Academic Press, New York, London, pp 1836–1843
Cryer PE (1976) Isotopic derivative measurement of plasma norepinephrine and epinephrine in man. Diabetes 25: 1071–1082
Hawk PB (1947) Kjeldahl method. In: Practical physiological chemistry, 12th edn. Blakiston, Toronto, pp 814–822
DeFronzo RA, Soman V, Sherwin RS, Hendler R, Felig P (1978) Insulin binding to monocytes and insulin action in human obesity, starvation and refceding. J Clin Invest 62: 204–213
Lins PE, Efendic S (1976) Hyperglycemia induced by somatostatin in normal subjects. Horm Metab Res 8: 497–498
Sherwin RS, Tamborlane W, Hendler R, Sacca L, DeFronzo RA, Felig P (1977) Influence of glucagon replacement on the hyperglycemic and hyperketonemic response to prolonged somatostatin infusion in normal man. J Clin Endocrinol Metab 45: 1104–1107
Sherwin RS, Hendler R, DeFronzo RA, Wahren J, Felig P (1977) Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin. Proc Natl Acad Sci 74: 348–352
Steele R (1959) Influence of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci USA 82: 420–430
Thiébaud D, Jacot E, DeFronzo RA, Maeder E, Jéquier E, Felber JP (1982) The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man. Diabetes 31: 957–963
Reinmuth OM, Scheinberg P, Bourne B (1965) Total cerebral blood flow and metabolism. Arch Neurol 12: 49–66
Scheinberg P (1965) Observations on cerebral carbohydrate metabolism in man. Ann Int Med 62: 367–371
Owen OE, Morgan AP, Kemp HG, Sullivan JM, Herrera MG, Cahill GF (1967) Brain metabolism during fasting. J Clin Invest 46: 1589–1595
Owen OE, Reichard GA Jr, Boden G, Shuman C (1974) Comparative measurements of glucose, beta-hydroxybutyrate, acetoacetate, and insulin in blood and cerebrospinal fluid during starvation. Metabolism 23: 7–14
Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE (1980) Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 238: E69-E82
Altszuler N, Gottlieb B, Hampshire (1976) Interaction of somatostatin, glucagon and insulin on hepatic glucose output in the normal dog. Diabetes 25: 116–121
Cherrington AD, Chiasson JL, Liljenquist JE, Jennings AS, Keller U, Lacy WW (1976) The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog. J Clin Invest 58: 1407–1418
Cherrington AD, Caldwell MD, Dietz MR, Exton JH, Crofford OB (1977) The effect of somatostatin on glucose uptake and production by rat tissues in vitro. Diabetes 26: 740–747
Gerich JE, Lorenzi M, Bier DM, Tsalikian E, Schneider V, Karam JH, Forsham PH (1976) Effect of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. J Clin Invest 57: 875–884
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Felber, J.P., Thiébaud, D., Maeder, E. et al. Effect of somatostatin-induced insulinopenia on glucose oxidation in man. Diabetologia 25, 325–330 (1983). https://doi.org/10.1007/BF00253195
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00253195